WASHINGTON (Reuters) – When scientists first unearthed fossils of a horned dinosaur called Centrosaurus in the badlands of Dinosaur Provincial Park in Canada’s Alberta province in 1989, they spotted a badly malformed leg bone they figured was a healed fracture... More »
(Reuters) – American actress Kelly Preston who has appeared in films including “Jerry Maguire” and “Twins”, has died aged 57 after battling breast cancer for nearly two years, her husband, John Travolta, announced in an Instagram post late on Sunday. “It is wi... More »
(Reuters) – The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Normal speech sprays droplets with contagious coronavirus The thou... More »
FRANKFURT (Reuters) – German drugs and pesticides company Bayer said the economic downturn has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer, even as its earnings rose. The pandemic has significant... More »
LONDON (Reuters) – It’s 2023. Britain’s brightest and best drug researchers are packing their bags as clinical trials start to dwindle, leaving a nation renowned as a global leader in pharmaceutical development to face a future in the slow lane. This is a wors... More »
(Reuters) – The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s Keytruda for a hard-to-treat form of bladder cancer, making it the first new treatment for the cancer in more than two decades. The therapy was approved for patien... More »
(Reuters Health) – Cancer death rates in the United States fell 2.2% from 2016 to 2017 – the largest single-year drop ever recorded – fueled in large part by progress against lung cancer, the leading cause of cancer death, the American Cancer Society (ACS) rep... More »
(Reuters) – The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG liable in the case of a California man who blamed its Roundup weed killer for his cancer. The gov... More »
(Reuters) – GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called c... More »
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday. Out of 101 patients teated with Yescarta for ... More »
(Reuters) – Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial. The company said it will apply for U.S. approval for the treatm... More »
(Reuters) – Bristol-Myers Squibb Co and bluebird bio Inc said on Friday their experimental therapy for a type of multiple myeloma met the main goal in a mid-stage study. The study evaluated the efficacy and safety of the therapy, Ide-cel, in patients who had r... More »
NEW YORK (Reuters) – Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. The French drugmaker said it was working with health autho... More »
NEW YORK (Reuters) – Cash-strapped WeWork, the office-sharing company that is trying to negotiate a financial lifeline, has a new problem that may prove costly. It has closed about 2,300 phone booths at some of its 223 sites in the United States and Canada aft... More »
BARCELONA (Reuters) – GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian cancer patients, possibly helping GSK catch its rival in a highly contested drug class. The two ... More »
(Reuters) – An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest dose in a small, early-stage trial, the company said on Saturday. The cancer... More »
(Reuters Health) – Women who exhibit many classic symptoms of post-traumatic stress disorder (PTSD) may be much more likely to develop ovarian cancer than their counterparts who don’t, a new study suggests. For the study, researchers asked women to identify th... More »
(Reuters Health) – Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, a new survey suggests. The survey of doctors from a Midwestern health system found that on... More »
Increasing numbers of middle-aged Americans appear to be developing cancers that can be associated with obesity, new data suggest. And the increase in these cancers among 50- to 64-year-olds parallels the rising rates of obesity, researchers say. In their anal... More »
(Reuters) – Roche Holding AG has priced its personalized cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of the monthly price of a rival drug from Bayer AG and Eli Lilly and Co that was approved last year. Roche’s drug and Bayer/Lilly’s Vi... More »
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease. Inrebic belongs to a class of drugs kno... More »
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said, dismissing a report to that effect which drove its shares as much as 11% high... More »
GENEVA (Reuters) – Electronic cigarettes and heated tobacco products are not helping fight cancer, the World Health Organization (WHO) said on Friday, urging smokers and governments not to trust claims from cigarette firms about their latest products. The seve... More »
LONDON (Reuters) – Healthy progress has been made in reducing smoking and tobacco use, but governments need to do more to help the world’s 1.1 billion smokers quit, the World Health Organization said on Friday. Tobacco use has also declined proportionately in ... More »
(Reuters) – GlaxoSmithKline said on Monday a late-stage study testing its initial maintenance therapy, Zejula, in patients with ovarian cancer who have undergone platinum-based chemotherapy showed positive results. Zejula, which belongs to a promising class of... More »
ZURICH (Reuters) – Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world’s biggest maker of cancer drugs pushes ahead in personalized medicines that require a biomarker test to identify prospective patients. Roche said Japan is the ... More »
(Reuters) – Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs. The largest U.S. drugmaker agreed to pay a hefty premium ... More »
LOS ANGELES (Reuters) – Dave Mustaine, lead singer and guitarist for the heavy metal band Megadeth, has been diagnosed with throat cancer, forcing the band to cancel most of its 2019 shows, he said on Monday. Megadeth had been scheduled to perform this year in... More »
For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these centers isn’t very different from that received at other top-notch facilities. Since the early... More »
CHICAGO (Reuters) – The U.S. Department of Agriculture has confirmed the discovery of unapproved, genetically modified (GM) wheat plants growing in an un-planted agricultural field in Washington state. There was no evidence the wheat had entered the food suppl... More »
(Reuters) – AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage trial. The company’s shares fell 1.8 percent to $78.10 before the b... More »
(Reuters Health) – Patients who see their doctors in the morning are a lot more likely to be referred for screenings for breast and colon cancer than patients with end-of-the-day appointments, a new study suggests. Researchers poring over records of more than ... More »
BUENOS AIRES (Reuters) – Amid a swirling economic crisis and protests over budget cuts for research in Argentina, one scientist has found a novel way to fundraise: winning money on a television game show. Marina Simian, a biologist for Argentina’s National Sci... More »
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension. The U.S. Food and D... More »
(Reuters Health) – Patients may have less access to palliative care at U.S. hospitals that primarily serve minorities, a study suggests. Minorities in the U.S. often receive worse healthcare and have worse outcomes, researchers note in JAMA Network Open. Non-w... More »
(Reuters) – Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development. Lilly Chief Execut... More »
(Reuters) – A California jury on Monday heard opening statements in the latest trial over allegations that Johnson & Johnson’s (JNJ.N) talc-based products, including the company’s baby powder, were contaminated with asbestos and cause cancer. The lawsuit broug... More »
(Reuters Health) – Although space travel exposes astronauts to forms of radiation that are uncommon on Earth, and that are linked to cancers and heart problems, a U.S. study suggests this doesn’t significantly shorten their lives. Researchers compared nearly 6... More »
(Reuters) – Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. The results showed the drug, Bavencio, in combination with, or as a follow-on treatment ... More »
HAVANA (Reuters) – Once a month for the last decade, Pepe Casanas, a 78-year-old Cuban farmer, has hunted down a scorpion to sting himself with, vowing that the venom wards off his rheumatism pains. His natural remedy is no longer seen as very unusual here. Re... More »
(Reuters Health) – – Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with the disease, a research review suggests. The study team examined data f... More »
(Reuters Health) – At age 76 the risks of a repeat colonoscopy may exceed the benefits for seniors whose previous screenings have found no signs of cancer, but many older adults don’t like the logic behind this guideline based on life expectancy. A new study s... More »
NEW YORK (Reuters) – When companies try to tackle rising healthcare costs, shifting more of the burden to employees is increasingly the strategy of choice. But Activision Blizzard, an entertainment company that employs more than 6,000 people in the United Stat... More »
OSLO (Reuters) – Norway’s Ultimovacs plans to raise around 700 million Norwegian crowns ($82 million) in an initial public offering in early 2019 to help fund the development of its immunotherapy cancer drug. “Our main investors are positive and will take a si... More »
(Reuters Health) – A screening test for colon cancer that looks for “invisible” blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests. Researchers examined data on 133,921 adults in Scotland who got scr... More »
(Reuters) – Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation. The company plans to launch the drug, Tibsovo, in t... More »
LONDON (Reuters) – AstraZeneca (AZN.L) suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit. Yet today two-thirds of analysts tracked by Thomson Reuters recommend t... More »
LONDON (Reuters) – AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets. The decisions by the Japanese Ministry of Health, Labour and ... More »
(Reuters) – A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J’s baby powder, citing a U.S. Supreme court ... More »
(Reuters Health) – Childhood cancer survivors who get plenty of vigorous exercise may live longer than their counterparts who aren’t very active, a recent study suggests. “In cancer survivors, cancer treatment causes what we consider to be an accelerated aging... More »
(Reuters Health) – U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests. “This study is the first to show higher prevalences of... More »
(Reuters Health) – Adult survivors of childhood cancer are at risk for serious chronic medical problems, but many of them are not particularly concerned about their future health, a study suggests. In a survey of 15,620 adult survivors of childhood cancer and ... More »
Chicago (Reuters) – Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co’s cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led at least one Wall Street analyst to reassess expectations. Bristol... More »
CHICAGO (Reuters) – In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines. The U.S. Food and Drug Administration chi... More »
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said on Sunday. “This is a major finding,” said Dr. La... More »
CHICAGO (Reuters) – Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementi... More »
CHICAGO (Reuters) – The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up front to make sure applications companies submit are complete. The new approach, outlined on Saturda... More »
CHICAGO (Reuters) – In a disappointment for Roche Holding AG (ROG.S), two of its oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials presented on Saturday. Ad... More »
CHICAGO (Reuters) – An experimental cancer drug from Loxo Oncology performed even better in patients with a rare mutation of the RET gene than previously reported, according to updated results from an early stage clinical trial presented on Saturday. Last mont... More »
CHICAGO (Reuters) – Lynch syndrome, a rare hereditary disease typically associated with an increased risk of colorectal and endometrial cancers, appears to be linked with several additional types of cancer than previously thought, U.S. researchers said on Satu... More »
CHICAGO (Reuters) – An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by tumors, according to preliminary results released on Saturday. The findings, presented at ... More »
CHICAGO (Reuters) – Patients with advanced multiple myeloma treated with bluebird bio’s experimental immunotherapy lived for a median of nearly a year before their cancer worsened, according to data from a small study presented on Friday. The treatment, called... More »
COPENHAGEN (Reuters) – Shares in Danish biotech Genmab fell by as much as 25 percent on Monday after its partner Johnson & Johnson decided to ditch a study using its blockbuster cancer drug. Genmab said Janssen, a Johnson & Johnson business, had decided that t... More »
LONDON (Reuters) – Prime Minister Theresa May will call on Britain’s health service, charities and artificial intelligence sector to work together to better identify patients with the early stages of cancer and stop thousands dying each year. May, who is strug... More »
(Reuters Health) – Under the Affordable Care Act (ACA) provision allowing adult children to stay on their parents’ health insurance policy until age 26, young women with gynecological cancers were diagnosed and treated sooner, researchers say. Before the law, ... More »
(Reuters) – A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her exposure to cancer-causing asbestos began in South Carolina on Monday in the latest case against the healthcare conglomerate and a... More »
(Reuters Health) – Hair products used primarily by black women and children contain a host of hazardous chemicals, a new study shows. The findings could explain at least in part why African-American women go through puberty earlier and suffer from higher rates... More »
(Reuters Health) – An overactive immune response, which can occur with viral infections, could result in sudden hair graying, according to research in mice. The research revealed that a molecule involved in hair pigmentation also controls certain immune system... More »
LONDON (Reuters) – In London’s world-famous Great Ormond Street children’s hospital, Dr. Karin Straathof is excited about a new cell-based medicine that offers hope for toddlers with incurable nerve tissue cancer. Her progress with a handful of children for wh... More »
(Reuters) – AbbVie Inc reported a better-than-expected quarterly profit on Thursday, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs, leading the company to raise its full-year earnings forecast. The company’s shares, whi... More »
NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J’s Baby Powder could open a new front for thousands of cases claiming the wide... More »
LONDON (Reuters) – Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. The deal suggests there is value... More »
(Reuters Health) – The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money. Anticancer medications account for the lion’s share of glob... More »
(Reuters Health) – Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs, a U.S. study suggests. Researchers examined data on payments drug companies made to doctors in 201... More »
(Reuters Health) – Most Americans aren’t aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, a U.S. study suggests. In a nationally representative survey of 420 adults, just 16 percent said they knew... More »
(Reuters Health) – The proportion of boys and young men in the U.S. receiving the human papillomavirus (HPV) vaccine has more than tripled since 2011, new research shows. Among 9- to 26-year-old males, 27 percent had received at least one dose of the vaccine i... More »
(Reuters) – Starbucks Corp (SBUX.O) and other coffee sellers must put a cancer warning on coffee sold in California, a Los Angeles judge has ruled, possibly exposing the companies to millions of dollars in fines. A little-known not-for-profit group sued some 9... More »
(Reuters Health) – Thyroid surgery that totally or partially removes the gland may increase the long-term risk of bone thinning and bone breaks, especially for younger patients and women, according to a large study from Taiwan. In particular, osteoporosis and ... More »
(Reuters Health) – Adult survivors of childhood cancer have a greater risk of heart disease and develop risk factors like high blood pressure and elevated cholesterol earlier in life compared to the general population, a German study suggests. Researchers stud... More »
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo LONDON (Reuters) – AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall surviv... More »
FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany February 29, 2008. REUTERS/Fabrizio Bensch /File Photo LONDON (Reuters) – Drugmakers are racing to scoo... More »
(Reuters) – A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology’s lead breast cancer drug, an outcome the U.S drugmaker had signaled last month. The EMA said the Committee for Medicinal Products for Human Use (CHM... More »
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, ope... More »
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Swiss drugmaker Roche Holding AG (ROG.S) said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health ... More »
A woman uses her cell phones in Manhattan, New York, U.S., January 30, 2018. REUTERS/Andrew Kelly (Reuters) – Male rats exposed to very high levels of the kind of radiation emitted by cellphones developed tumors in the tissues around their hearts, according to... More »
NEW YORK (Reuters) – Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co. In a complaint filed in the... More »
(Reuters) – The U.S. Food and Drug Administration on Thursday approved a radioactive drug to treat the ultra-rare type of digestive tract cancer that killed Steve Jobs in 2011. The approval for Advanced Accelerator Applications SA’s Lutathera comes just days a... More »
FILE PHOTO: A man poses for a photograph while using a Philip Morris iQOS smoking device, in Bogota, Colombia November 14, 2017. REUTERS/Jaime Saldarriaga/File Photo WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim its iQOS... More »
LONDON (Reuters) – A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds ($27 million) from investors including GV, the venture capital arm of Google parent Alphabet Inc. Vacc... More »
Professor Ketan Patel works in the lab at MRC Laboratory of Molecular Biology in Cambridge, Britain January 2, 2018. Picture taken January 2, 2018. REUTERS/Chris Radburn LONDON (Reuters) – Drinking alcohol produces a harmful chemical in the body which can lead... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo (Reuters) – Swiss drugmaker Roche (ROG.S) will buy U.S. cancer drugmaker Ignyta Inc (RXDX.O) ... More »
(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics. The deal would come as large phar... More »
FILE PHOTO: Sen. John McCain (R-AZ) speaks at a press conference about the National Defense Authorization Act in Washington, U.S., October 25, 2017. REUTERS/Aaron P. Bernstein/File Photo WASHINGTON (Reuters) – Republican U.S. Senator John McCain is expected to... More »
LOS ANGELES (Reuters) – Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. Shares of Merck have fallen 10... More »
(Reuters) – More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc’s experimental gene-modifying immunotherapy in a small, early stage study, according to... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Adding Roche’s (ROG.S) immunotherapy Tecentriq to older drugs doubled the ... More »
FILE PHOTO: Genmab Chief Executive Jan van de Winkel poses for a photograph in London, Britain, October 13, 2016. REUTERS/Ben Hirschler/File Photo LONDON (Reuters) – Genmab (GEN.CO) was Europe’s second biggest biotech company, until its partner Johnson & Johns... More »
LONDON, (Reuters) – Doctors in France have found the first evidence that a drug normally used to treat lung, kidney or skin cancer may be able to eradicate HIV-infected cells in people with the AIDS virus. In a case described as potentially exciting by scienti... More »
FILE PHOTO: A Cappuccino stands on a table at a branch of Costa coffee in Manchester, Britain, March 18, 2016. REUTERS/Phil Noble/File Photo LONDON (Reuters) – People who drink three to four cups of coffee a day are more likely to see health benefits than harm... More »
FILE PHOTO: FILE PHOTO: Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecen... More »
